יחס חוב כולל להון עצמי SOPHiA GENETICS S.A. (SOPH)

The daily price action for SOPHiA GENETICS SA (SOPH) shown on this chart reflects a total debt-to-equity ratio of 0.68. Revenue deceleration is driven by the prolonged implementation of software in clinics, while cyber threats are mitigated by liquid assets. The business is developing cloud-based AI for genome analysis, expanding its reach by consolidating global institutions. Revenue relies on subscriptions from research centers and pharmaceutical behemoths.

Scaling the cloud genomic platforms of SOPHIA GENETICS SA (SOPH) requires strict control over debt load, as reflected in the financial stability ratio chart. This metric determines the extent of the business's reliance on borrowed funds relative to its own equity. The calculation is performed by dividing total liabilities by the net asset value of the owners. Low values confirm the company's financial autonomy, while high leverage, under effective management, can accelerate the expansion of diagnostic services.